Monthly Archives: September 2020

Pharmaceutical Antitrust Litigation Updates – Sept. 1, 2020

Schneider Wallace Cottrell Konecky is tracking major pharmaceutical litigation news for clients and counsel.

In this update, we cover a DOJ False Claims Act complaint against Teva for kickbacks for Copaxone, certification of a class against Merck for Zetia direct purchasers, a settlement by Actavis for Intuniv, certification of a class against Bausch for Glumetza direct purchasers, and denial of a motion to dismiss by Mallinckrodt on Acthar.